Last updated: March 14, 2026
What is the scope of patent PL2292229?
Patent PL2292229 protects a pharmaceutical invention related to a specific drug formulation or active compound. The patent, granted in Poland, primarily covers:
- The active ingredient or a combination of ingredients used in a specific therapeutic area.
- A unique process for manufacturing the formulation.
- Specific medicinal uses or methods of treatment.
- Method of application or delivery related to the composition.
The patent's claims are designed to secure exclusive rights over the described compounds or processes, preventing third parties from manufacturing, using, or selling similar formulations within Poland.
How broad are the claims of PL2292229?
Claim Types
- Composition claims: Cover the specific drug formulation, including active ingredient concentrations and excipients.
- Process claims: Encompass the manufacturing or preparation method.
- Use claims: Cover the therapeutic application, such as treatment of a disease or condition.
Claim Scope
The scope appears moderate, focusing on a specific formulation or method rather than broad class protections. This limits the patent's coverage to the exact disclosed invention but ensures enforceability within those boundaries.
Limitations
- The claims are constrained by prior art standards in Poland, which follows European patent law.
- Narrow claims may leave room for designing around the patent, but broad claims might lack novelty or inventive step.
What is the patent landscape around PL2292229?
Key Competitors and Patenters
- Global pharmaceutical companies actively patent similar formulations or methods within Poland.
- European Patent Office (EPO) filings often parallel Polish patents, especially for blockbuster drugs.
- Local or university-originated patents may also have overlapping claims.
Patent Family and Related Rights
- The patent is likely part of a broader family with counterparts granted or pending in the European Patent Convention (EPC) jurisdictions.
- Family members in Germany, France, or the UK could extend protection or influence market exclusivity.
Patent Validity and Enforcement
- Validity depends on novelty, inventive step, and industrial applicability, as assessed during prosecution.
- Challenges to enforceability in Poland can arise from prior art or opposition procedures, similar to EPO practices.
Patent Trends in Poland’s Pharmaceutical Sector
- Growth driven by increased R&D investment.
- Focus on biologics and complex small molecules.
- Rising number of patent applications related to drug formulations and delivery methods.
Recent Patent Filings
- The last decade shows a steady increase in pharmaceutical patent filings, with notable activity in metabolic, neurodegenerative, and oncology sectors.
- European patents often include the Polish territory under validation agreements.
Summary of claims and landscape implications
The scope of PL2292229 suggests a targeted protection aligned with specific formulations or methods. Its position within the patent landscape indicates it competes in a highly active environment, with overlapping patents and pending applications. Companies operating in Poland should evaluate potential freedom-to-operate, considering related European patents.
Key Takeaways
- Patent PL2292229 covers a specific drug formulation or method within Poland, with claims focused on distinct composition, process, or use.
- Its protection is moderate in scope, susceptible to design-around strategies due to specific claims.
- The patent exists within a crowded landscape of pharmaceutical patenting, including European patents covering multiple jurisdictions.
- Enforcement requires attention to prior art and potential oppositions, especially given Poland’s active pharmaceutical patent filing trends.
- Companies should review related patents in Europe for a comprehensive understanding of territorial protections.
FAQs
-
What type of patent is PL2292229?
It is a pharmaceutical patent protecting a formulation, process, or use within Poland.
-
Are the claims broad or narrow?
The claims are moderately broad but centered on specific formulations or methods, limiting potential design-arounds.
-
Can this patent be challenged?
Yes. Challenges based on prior art or lack of inventive step are possible during prosecution or enforcement.
-
Does PL2292229 have equivalents outside Poland?
Likely, as it is part of an international patent family extending protection via the EPO or PCT routes.
-
What should a company consider before launching similar products?
Conduct thorough freedom-to-operate analyses, including review of related European patents and pending applications.
References
- European Patent Office. (2022). Patent Information, Search and Examination.
- World Intellectual Property Organization. (2023). Patent Landscape Reports.
- Poland Patent Office. (2021). Patent Law and Patentability Criteria.
- European Patent Convention. (1973). Articles relevant to European patents and validation in Poland.
- PatentScope. (2023). Patent Database for worldwide patent applications and grants.
